The first province in the country requires all pharmacy filing.

Medical representatives have been regulated and upgraded. They will not be registered online by the end of this month. They will not be able to enter all hospitals in Hubei Province.

According to the official website of the Hubei Provincial Pharmaceutical Bureau, on September 2, the market supervision system of Huanggang City, Hubei Province issued the "Reminder of the Reminder of the Infrastructure Governance Work in the Field of Drug Purchase and Sales" to the city. Medical institutions such as the toilet issued reminders.

This is the first phase of the first stage of the management of unconventional wind governance in Hubei Province. The Kenji Bureau was informed that in the next step, the medical institution to check the filing of medical representatives, incorporated the important content of the market supervision department's entry supervision, and increase the joint punishment of illegal acts.

In fact, the Hubei Provincial Drug Administration issued a notice in July that all pharmaceutical representatives in the province need to report the filing information to the "National Medicine Representative Record Platform" before September 30 to timely maintain the change of information and publicize it as required.

Hubei is the first province that publicly requested pharmaceutical representatives to record online.

Fill in before the end of the month, do not allocate sales tasks

Hubei requires all pharmaceutical listing permit holders, pharmaceutical manufacturers, and pharmaceutical business enterprises to register on the national pharmaceutical representative filing platform in accordance with the requirements of the "Pharmaceutical Representative Recording Management Measures (Trial)".

This is a response to the management measures of national medical representatives.

In September 2020, the "Management Measures for the Record of Medical Representative (Trial)" was officially introduced. For the first time, the nature of the medical representative's work was clearly transmitted to medical institutions, academic promotion, collection of adverse reactions of drugs, and regulating the intra -hospital behavior of medical representatives. Drug sales tasks. Soon after, the Chinese Pharmaceutical Association launched the "Pharmaceutical Representative Pilot Platform".

Theoretically, medical representatives need to register their own personal information, academic qualifications, proxy drug treatment fields, training information, etc. on the filing platform. As long as they enter the filing number or the unit and name of the medical representative, anyone can find this information.

This is the first step in the standardized drug sales. Since 2019, Beijing, Guangxi, and Yunnan have been called sponsored by pharmaceutical companies to comprehensively investigate the academic meeting. The industry generally believes that with the gradual professionalization of medical information, the former enviable medical representative living environment is getting worse and worse.

Under the influence of the epidemic in the past two years, a number of nationwide hospitals such as Xiangya Second Hospital of Hubei and a tumor hospital in Guangzhou notified to various pharmaceutical companies that the medical representatives are strictly prohibited to enter the doctor's clinic and office. Drugs involved. This is another restraint on the promotion behavior of medical representatives.

Today, Hubei forced all medical representatives to record, and there will definitely be strict hospital access rules in the future.

According to the plan, various pharmaceutical companies must fill in the "Promotion of the Inscadence of the Field of Drug Purchasing and Sales" by September 30, and submit it to the city and state market supervision bureaus and provincial bureaus branches. The commitment request: Pharmaceutical companies consciously implement the "Management Measures for the Record of Medical Representatives". They must not distribute sales tasks for pharmaceutical representatives, shall not be unified, and shall not directly provide sponsorship of hospital departments and individuals.

Medical institutions' pharmaceutical filing situation has been included in daily supervision by drug supervision departments at all levels. If there is violations, pharmaceutical companies will voluntarily accept the punishment of relevant departments in accordance with the law.

Pharmacy bribery, the legal person assumes the responsibility of "sitting"

If the medical representative is illegal, this time Hubei Province has refined the punishment regulations.

The "Notice" clearly states that the circumstances are serious and involved in the province's drug -related units, and the market supervision department will punish and revoke a business license. The pharmaceutical regulatory department has issued a revocation of drug approval documents, drug production licenses, and drug business licenses.

At the same time, if you bribe with state staff, the legal representative, the principals, the person in charge of the person in charge of the enterprise, and the person in charge of the person in charge are prohibited from engaging in drug production and operation activities for life. This means that once the medical representative will be arrested in the future, the executives or legal persons of the company involved will also be held accountable.

Picture source: Jingmen Market Supervision and Administration Bureau

Analysts pointed out that the introduction of this penalty measure will be deterrent to the management model of pharmaceutical companies. Pharmaceutical companies have previously pushed all responsibilities to "internship employees" or third -party outsourcing.

With the increase of major pharmaceutical companies' importance to innovative medicines, the speed of innovation drugs has continued to accelerate, and the ability of pharmaceutical representatives has gradually enlarged. How to correctly communicate with medical institutions is a problem in front of each pharmaceutical company.

In fact, since the formulation of the medical representative's filing system, the supervision of strict implementation of strict implementation is not as powerful as Hubei.

The "Notice" requires that medical institutions should check the filing information of the medical representative on the filing platform in a timely manner. Based on this, the phenomenon such as "Pharmaceutical Pharmaceutical White Coats Pretend to Do a doctor" should be avoided. Medical representatives are not so easy to develop and maintain the relationship with hospital doctors.

With the in -depth advancement of medical reform, medical representatives need to change from "relations" and "transaction" to "technology".

According to the "Notice of the Essential Points of the Unhealthy Work Points in the Field of Medicine Purchase and Sales and Medical Services in 2022" in June this year, it is pointed out that it has gradually improved the management specifications of cooperation in cooperation between medical institutions and pharmaceutical enterprises, and continuously regulates that medical institutions accept donations, and to receive donations, and to receive donations, and to receive donations, and to receive donations, medical institutions accept donations, and to receive donations, Clinical scientific research, academic conferences or projects such as projects.

In recent years, the Chinese pharmaceutical market environment has changed, and the departure rate of pharmaceutical representatives has increased significantly. Many well -known pharmaceutical companies such as Novartis, Astraon, Sanofi, Hengrui, and East Sunshine have laid off.Data show that 70%of the 3 million medicine agents across the country are preparing to transform.There is no doubt that China's pharmaceutical industry is completely subverted and enterprises, and the large waves of large pharmacies are accelerating.Prior to this, under the change of market rules and the pressure of anti -corruption, the bitter days of medical representatives had arrived.

Writing | Lei Gong

Edit ｜ Jiang Yun Jia Ting

Operation | Valley

Illustration | Visual China

####

- END -